2021 BAD指南:红斑痤疮患者的治疗

2021-10-01 英国皮肤科医师协会 Br J Dermatol

2021年10月,英国皮肤科医师协会(BAD)发布了红斑痤疮患者的治疗指南,主要目的是为红斑痤疮的治疗提供最新循证指导建议,指南不涉及诊断以及儿童患者的管理证据。

中文标题:

2021 BAD指南:红斑痤疮患者的治疗

英文标题:

British Association of Dermatologists guidelines for the management of people with rosacea 2021

发布机构:

英国皮肤科医师协会

发布日期:

2021-10-01

简要介绍:

2021年10月,英国皮肤科医师协会(BAD)发布了红斑痤疮患者的治疗指南,主要目的是为红斑痤疮的治疗提供最新循证指导建议,指南不涉及诊断以及儿童患者的管理证据。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 BAD指南:红斑痤疮患者的治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=b9c3a1c002215edd, title=2021 BAD指南:红斑痤疮患者的治疗, enTitle=British Association of Dermatologists guidelines for the management of people with rosacea 2021, guiderFrom=Br J Dermatol, authorId=0, author=, summary=2021年10月,英国皮肤科医师协会(BAD)发布了红斑痤疮患者的治疗指南,主要目的是为红斑痤疮的治疗提供最新循证指导建议,指南不涉及诊断以及儿童患者的管理证据。, cover=https://img.medsci.cn/20211019/1634652483735_5579292.jpg, journalId=0, articlesId=null, associationId=173, associationName=英国皮肤科医师协会, associationIntro=英国皮肤科医师学会(British Association of Dermatologists,BAD)成立于1920年,是一家由英国和爱尔兰皮肤科医生学者组成的专业组织。网站提供大量的临床指南,氨基丙名称分类,并明确标出5年内,5年以上及最近更新,可直接下载。拥有BJD及CED两本期刊。, copyright=0, guiderPublishedTime=Fri Oct 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年10月,英国皮肤科医师协会(BAD)发布了红斑痤疮患者的治疗指南,主要目的是为红斑痤疮的治疗提供最新循证指导建议,指南不涉及诊断以及儿童患者的管理证据。</span></p>, tagList=[TagDto(tagId=56478, tagName=红斑痤疮)], categoryList=[CategoryDto(categoryId=39, categoryName=皮肤与性病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=56478, guiderKeyword=红斑痤疮, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3006, appHits=114, showAppHits=0, pcHits=627, showPcHits=2892, likes=1, shares=7, comments=4, approvalStatus=1, publishedTime=Wed Oct 20 12:48:52 CST 2021, publishedTimeString=2021-10-01, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Wed Oct 20 12:18:43 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Thu Jan 04 02:38:06 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 BAD指南:红斑痤疮患者的治疗.pdf)])
2021 BAD指南:红斑痤疮患者的治疗.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1196737, encodeId=0f2e1196e370b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2386506710, createdName=ms3000001862313380, createdTime=Thu Feb 24 10:22:18 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192467, encodeId=659a119246e7a, content=非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Fri Feb 11 21:41:20 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069237, encodeId=0a16106923eef, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ca01520970, createdName=xyxymr2, createdTime=Thu Nov 11 11:42:31 CST 2021, time=2021-11-11, status=1, ipAttribution=)]
    2022-02-24 ms3000001862313380

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1196737, encodeId=0f2e1196e370b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2386506710, createdName=ms3000001862313380, createdTime=Thu Feb 24 10:22:18 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192467, encodeId=659a119246e7a, content=非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Fri Feb 11 21:41:20 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069237, encodeId=0a16106923eef, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ca01520970, createdName=xyxymr2, createdTime=Thu Nov 11 11:42:31 CST 2021, time=2021-11-11, status=1, ipAttribution=)]
    2022-02-11 ms3000000637975859

    非常有用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1196737, encodeId=0f2e1196e370b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2386506710, createdName=ms3000001862313380, createdTime=Thu Feb 24 10:22:18 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192467, encodeId=659a119246e7a, content=非常有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Fri Feb 11 21:41:20 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069237, encodeId=0a16106923eef, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ca01520970, createdName=xyxymr2, createdTime=Thu Nov 11 11:42:31 CST 2021, time=2021-11-11, status=1, ipAttribution=)]
    2021-11-11 xyxymr2

    非常好

    0

拓展阅读

2022 S2k 指南:酒渣鼻

德国皮肤病学会 (DDG) · 2022-08-05

EADV立场声明:酒渣鼻/红斑痤疮患者的生活质量测量

欧洲皮肤病与性病学会(EADV,European Academy of Dermatology and Venereology) · 2023-02-06